bpc-157 human clinical trials status fda approval KevinMD.com Peptide BPC-157 - Does It
Description
None are randomized controlled trials
Sermorelin is a synthetic analogue of growth hormonereleasing hormone (GHRH)
Dosing: Provider-determined (Weekly injection)
While some studies suggest very short-lived protection against infection but stable protection against severe outcomes, methodological flawssuch as inconsistent follow-up, selective exclusion, and case-counting window biasundermine claims of protection
57 KatohT.SatoK.KawamuraM.IwataH.MiuraT
Psychiatry 22 , 11721184 (2017)
